[Paradigm Shift in Ovarian Tumor Pathology from the View of Genomic Abnormalities].

Abstract excerpt

A decade of accumulated evidence has led to significant progress and a paradigm shift in ovarian tumor pathology. Now, ovarian carcinoma is widely recognized as a heterogeneous group of neoplasms with regard to histogenesis and underlying molecular mechanisms. Ovarian carcinoma is, therefore, divided into 2 clinicopathologic groups: type 1 and type 2 tumors. Type 1 tumors arise in association with benign...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Endometrial Neoplasms
• Share to Genome, Human
• Share to Mutation